HowShorted

How shorted is Fate Therapeutics, Inc.?

More shorted than 65% of the 2,877 ranked US companies

6.59%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+0.31
5 reports (~10 weeks)
−1.76
Aggregate net short position time series for Fate Therapeutics, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 20266.59%+0.31
15 Jul 20266.28%−0.10
30 Jun 20266.38%−2.90
15 Jun 20269.28%+0.10
29 May 20269.18%+0.83
15 May 20268.35%−0.54
30 Apr 20268.89%−0.02
15 Apr 20268.91%+0.36
31 Mar 20268.55%+0.47
13 Mar 20268.08%−0.21
27 Feb 20268.29%−1.36
13 Feb 20269.65%−0.24
30 Jan 20269.89%−0.03
15 Jan 20269.92%+1.19
31 Dec 20258.73%+1.09
15 Dec 20257.64%+0.54
28 Nov 20257.10%+0.52
14 Nov 20256.58%+0.66
31 Oct 20255.92%−0.62
15 Oct 20256.54%−0.39
30 Sep 20256.93%−1.63
15 Sep 20258.56%+0.19
29 Aug 20258.37%+0.22
15 Aug 20258.15%+0.05
31 Jul 20258.10%–

Frequently asked questions

How shorted is Fate Therapeutics, Inc. right now?
6.59% of Fate Therapeutics, Inc.'s (FATE) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.